-The Hindu Business Line As the Food Security Bill awaits Parliament clearance, India fears that implementation of obligations under the Bill may lead to breach of farm subsidy limits fixed by the World Trade Organisation (WTO) and attract penalties if some global rules are not amended. New Delhi is, therefore, scouting for support at the WTO in seeking an amendment to the Agreement on Agriculture (AOA) to remove limits on public stockholding...
More »SEARCH RESULT
Total Matching Records found : 400
Blame Govt for high wheat prices -CP Chandrasekhar and Jayati Ghosh
-The Hindu Business Line The general tendency among Indian policy makers currently is to blame international price movements for the rise in prices of essential food items in India. The extent to which this claim is valid is assessed by examining the specific case of wheat. It is no secret that Indian food prices are increasingly affected by international prices. Ever since 2002, when all quantitative restrictions on Indian imports of agricultural...
More »Strong medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »The Larger Implications of the Novartis Glivec Judgment-Sudip Chaudhuri
-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...
More »Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »
